CMP: 2120

Solvay Pharma India Ltd. manufactures pharmaceuticals. The Company produces drugs used to treat diseases in the fields of gastroenterology, women's health, and mental healthcare. Solvay Pharma India markets its products in cities located throughout India.

Solvay Pharma is a decent bet in pharma space. Minimal liabilities makes it a safer bet. Its currently trading at a P/E of 21 with decent dividend yields of 1.20% in the last 12 months. Revenues have grown slowly and steadily from 144 Crores to 296 Crores in the last 5 years. Profits have grown at a faster pace from 19 Crores to 51 Crores aided by NPM growth in the same period. NPM has grown from 12.50% to 17% over 5 years. Buy with long term perspective for safe gains of around 30% a year.